154 related articles for article (PubMed ID: 12638168)
1. [A review of epidemiological studies about the incidence and etiological factors of cryptorchidism--relevance to endocrine-disrupting chemicals].
Kurahashi N; Kishi R
Nihon Eiseigaku Zasshi; 2003 Jan; 57(4):636-44. PubMed ID: 12638168
[TBL] [Abstract][Full Text] [Related]
2. [Exposure to endocrine disrupting chemicals and human health: a review of epidemiological studies focused on hypospadias and cryptorchidism].
Kurahashi N; Kasai S; Saijo Y; Sata F; Kishi R
Nihon Eiseigaku Zasshi; 2005 Jan; 60(1):15-22. PubMed ID: 15773293
[TBL] [Abstract][Full Text] [Related]
3. Cryptorchidism and endocrine disrupting chemicals.
Virtanen HE; Adamsson A
Mol Cell Endocrinol; 2012 May; 355(2):208-20. PubMed ID: 22127307
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of micropenis in 2710 male newborns from an intensive-use pesticide area of Northeastern Brazil.
Gaspari L; Sampaio DR; Paris F; Audran F; Orsini M; Neto JB; Sultan C
Int J Androl; 2012 Jun; 35(3):253-64. PubMed ID: 22372605
[TBL] [Abstract][Full Text] [Related]
5. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities.
Gill WB; Schumacher GF; Bibbo M; Straus FH; Schoenberg HW
J Urol; 1979 Jul; 122(1):36-9. PubMed ID: 37351
[TBL] [Abstract][Full Text] [Related]
6. Contribution of prenatal endocrine-disrupting chemical exposure to genital anomalies in males: The pooled results from current evidence.
Wu Y; Wang J; Wei Y; Chen J; Kang L; Long C; Wu S; Shen L; Wei G
Chemosphere; 2022 Jan; 286(Pt 3):131844. PubMed ID: 34392196
[TBL] [Abstract][Full Text] [Related]
7. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring.
Stillman RJ
Am J Obstet Gynecol; 1982 Apr; 142(7):905-21. PubMed ID: 6121486
[TBL] [Abstract][Full Text] [Related]
8. [Exposure to endocrine disrupting chemicals and children's health: problems in epidemiological studies].
Kishi R; Sata F; Saijo Y; Kurahashi N; Kato S; Nakajima S; Sasaki S
Nihon Eiseigaku Zasshi; 2006 Jan; 61(1):19-31. PubMed ID: 16506651
[TBL] [Abstract][Full Text] [Related]
9. Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case-control study.
Gaspari L; Paris F; Jandel C; Kalfa N; Orsini M; Daurès JP; Sultan C
Hum Reprod; 2011 Nov; 26(11):3155-62. PubMed ID: 21868402
[TBL] [Abstract][Full Text] [Related]
10. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
[TBL] [Abstract][Full Text] [Related]
11. Genetic, Maternal, and Environmental Risk Factors for Cryptorchidism: An Update.
Barthold JS; Reinhardt S; Thorup J
Eur J Pediatr Surg; 2016 Oct; 26(5):399-408. PubMed ID: 27642851
[TBL] [Abstract][Full Text] [Related]
12. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
Dogan S; Simsek T
Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals.
Holmboe SA; Beck AL; Andersson AM; Main KM; Jørgensen N; Skakkebæk NE; Priskorn L
Front Endocrinol (Lausanne); 2024; 15():1343887. PubMed ID: 38633762
[TBL] [Abstract][Full Text] [Related]
14. Do environmental estrogens contribute to the decline in male reproductive health?
Jensen TK; Toppari J; Keiding N; Skakkebaek NE
Clin Chem; 1995 Dec; 41(12 Pt 2):1896-901. PubMed ID: 7497651
[TBL] [Abstract][Full Text] [Related]
15. Sexual differentiation and environmental endocrine disrupters.
Toppari J; Skakkebaek NE
Baillieres Clin Endocrinol Metab; 1998 Apr; 12(1):143-56. PubMed ID: 9890066
[TBL] [Abstract][Full Text] [Related]
16. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
[TBL] [Abstract][Full Text] [Related]
17. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study.
Fernandez MF; Olmos B; Granada A; López-Espinosa MJ; Molina-Molina JM; Fernandez JM; Cruz M; Olea-Serrano F; Olea N
Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):8-14. PubMed ID: 18174944
[TBL] [Abstract][Full Text] [Related]
18. Effect of the occupational environment of parents on cryptorchidism.
Mitsui T; Araki A; Miyashita C; Ito S; Kitta T; Moriya K; Shinohara N; Takeda M; Kishi R;
Pediatr Int; 2020 Nov; 62(11):1256-1263. PubMed ID: 32447789
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism.
Cederroth CR; Schaad O; Descombes P; Chambon P; Vassalli JD; Nef S
Endocrinology; 2007 Nov; 148(11):5507-19. PubMed ID: 17673513
[TBL] [Abstract][Full Text] [Related]
20. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies.
Storgaard L; Bonde JP; Olsen J
Reprod Toxicol; 2006 Jan; 21(1):4-15. PubMed ID: 16005180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
